The primary analysis showed that 82% of patients treated with iptacopan had at least a 2-g/dL Hb improvement without red blood cell (RBC) transfusions as compared with 2% of patients treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results